The Biomarkers That Actually Matter After 40
Standard checkups measure what's easy to measure. A handful of less commonly discussed markers tell a more honest story about how the next decade will go.
· 7 min
A standard annual check-up is a reasonable floor, not a ceiling. It reliably catches acute problems and gross abnormalities, but several of the markers most predictive of how the next ten to twenty years will unfold are not part of a typical basic panel. Tracking them reflects a longevity-first rather than anti-aging framework, prioritising function over appearance.
VO2 max
A direct measure of cardiovascular fitness — specifically, the maximum rate at which the body can use oxygen during exercise — VO2 max is one of the most consistently strong predictors of all-cause mortality in longitudinal research, independent of weight or cholesterol. It is measured through a graded exercise test, and unlike most biomarkers, it is also directly trainable.
hs-CRP and chronic inflammation
High-sensitivity C-reactive protein detects low-grade, chronic inflammation that standard panels miss. Persistently elevated levels are associated with increased cardiovascular and metabolic risk even when other markers look unremarkable — it's often the earliest visible signal that something is worth investigating further.
HOMA-IR and insulin sensitivity
Fasting glucose alone can look entirely normal for years while insulin resistance develops underneath it, because the body compensates by producing more insulin. HOMA-IR, calculated from fasting glucose and insulin together, surfaces that compensation earlier — often a decade before fasting glucose alone would flag a concern.
By the time fasting glucose is abnormal, insulin resistance has often been developing, unmeasured, for years.
Grip strength
A simple, thirty-second test with a dynamometer, grip strength is a well-validated proxy for overall skeletal muscle strength and has been linked in multiple large studies to outcomes as varied as cardiovascular risk and cognitive decline. It's one of the highest-value, lowest-cost measurements available.
ApoB
Where a standard lipid panel measures cholesterol concentration, ApoB measures the actual number of atherogenic particles carrying that cholesterol — a more direct measure of cardiovascular risk that can diverge meaningfully from a standard LDL result, particularly in people with otherwise 'normal-looking' lipid panels.
- VO2 max — cardiovascular fitness and the strongest single mortality predictor among these
- hs-CRP — chronic low-grade inflammation
- HOMA-IR — early insulin resistance, before fasting glucose changes
- Grip strength — a fast proxy for overall muscular and functional health
- ApoB — a more direct read on cardiovascular particle risk than standard cholesterol
Visceral fat — the metabolically active depot these markers are tracking risk around — is also a useful reference point when some subcutaneous fat pockets, like bra-line or flank fat, don't respond to diet and exercise as readily as expected: the two are different tissues with different behaviour, and only one of them is meaningfully captured by a metabolic biomarker panel.
These five markers sit alongside, rather than in place of, the newer category of biological age testing — a functional panel and a cellular-level result are answering related but distinct questions, and the most informative read usually comes from seeing whether the two actually agree.
Frequently Asked Questions
Are these markers available through a standard blood test?
hs-CRP, insulin (for HOMA-IR), and ApoB can usually be added to a standard blood draw on request. VO2 max and grip strength require simple additional tests, typically a graded exercise assessment and a handheld dynamometer respectively.
How often should these markers be reassessed?
Annually is a reasonable baseline for most of these, with VO2 max and grip strength sometimes tracked more frequently — every three to six months — if actively training to improve them.
Is an abnormal result in one marker cause for immediate concern?
Usually not on its own. These markers are most useful interpreted together and in trend over time, rather than as a single isolated result — a considered assessment looks at the overall pattern rather than reacting to one number.
Can these markers actually be improved, or are they largely fixed?
All five are meaningfully modifiable. VO2 max and grip strength respond directly to training; hs-CRP, HOMA-IR and ApoB respond to a combination of exercise, nutrition, sleep and, where appropriate, targeted medical treatment.
Clinical Perspective
By Dr. Gan Lee Ping
A standard annual panel is a reasonable floor, and I say that without criticism — it catches what it's designed to catch. But several of the patients I see after 40 are more interested in what the next two decades look like than in ruling out an acute problem today, and that requires a different set of numbers.
None of the five markers I discuss most often — VO2 max, hs-CRP, HOMA-IR, grip strength, ApoB — are exotic or hard to obtain, and none require a dramatic change in how a check-up is structured. What they require is asking for them specifically, and interpreting them as a trend rather than a single result.
Selected References
1. Strasser B, Burtscher M. Survival of the fittest: VO2max, a key predictor of longevity? Front Biosci (Landmark Ed). 2018;23(8):1505-1516.
2. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103(13):1813-1818.
3. Vogeser M, König D, Frey I, Predel HG, Parhofer KG, Berg A. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons. Clin Biochem. 2007;40(13-14):964-968.
4. Glavinovic T, Thanassoulis G, de Graaf J, Couture P, Hegele RA, Sniderman AD. Physiological bases for the superiority of apolipoprotein B over low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol as a marker of cardiovascular risk. J Am Heart Assoc. 2022;11(20):e025858.
About Dr. Gan Lee Ping
Dr. Gan Lee Ping is a Singapore aesthetic doctor with a clinical interest in facial anatomy, evidence-based aesthetic medicine, and natural-looking outcomes. Her educational articles focus on helping readers understand the anatomy, ageing processes and evidence behind aesthetic medicine so they can make informed decisions.
Consultation
Begin with a consultation
Every plan starts with an individual assessment — no protocol is recommended before one.
Book a ConsultationRelated in the Journal
Skin · Longevity
Skin Span and Skin Longevity: How to Keep Your Skin Looking Younger for Longer
Healthspan asks how many years a body stays functionally well. Skin span asks the same question of a single organ — and the answer is decided more by decades of habit than by any single treatment.
· 6 min
Skin · Longevity
Can NMN and NAD+ Really Slow Skin Ageing? A Doctor Reviews the Evidence
NMN and NAD+ have moved from longevity research into skincare marketing faster than the skin-specific evidence has kept pace. Here is what is actually established, and what is still assumption.
· 7 min
Longevity
Biological Age Testing: A Smarter Way to Personalise Your Anti-Ageing Treatment
A birthday is the same for everyone born on it. How a body and its skin are actually ageing is not — and a growing set of tests can now put a number on that difference.
· 7 min